Overview

At Home Diagnostics Market Introduction: At Home Diagnostics Market is calculated to value over US$ 6 billion by the end of 2027 and register at a CAGR of over 3% during the forecast period of 2020-2027. Tests that are performed on human body samples like blood, saliva and urine which can be used for detection of diseases or medical conditions

at home are called in-vitro diagnostics or home diagnostics. It is a popular test among the patient population as these tests are cost-effective, quick and confidential. The home diagnostic system is found in the form of a strip, digital monitoring instruments, dip cards, cups and cassettes. Growing awareness of home care testing among the population led to the potential growth of the market. Increasing epidemics of diseases has shifted the focus of the general population towards preventive healthcare rather than curative medicines. It created huge opportunities for manufacturers in this market. It is further augmented by changing demographics and increasing per capita healthcare expenditure due to increasing living standards led to the robust growth of the market. At home, diagnosis plays an important role in the preliminary diagnosis of disease and contained the cost of healthcare expenditure. As they are cost-effective and easy to use, patient adoption is high with limited technical knowledge. All these factors led to the burgeoning growth of the market North America and Europe dominated the global market due to high awareness among the general population. In North America, US accounts 90% market share due to high adoption. In Europe, UK Germany and France dominated the global market due to high penetration among the general population. The Asia Pacific and Latin America is the most opportunistic market for manufacturers due to the large patient population. They both were expected to witness high growth rate during the forecast period. Rest of the World accounts the small fraction of the market and it is expected to account more share during the later phase of the forecast period. At Home Diagnostics market players include: Thermo Fisher Scientific, SYNLAB, Siemens Healthcare Private Limited, Roche Diagnostics, Drägerwerk AG & Co. KGaA, Beckman Coulter, Inc., Abbott Laboratories and others. At Home Diagnostics Market Segmentation: By Application Allergy Detection

Fertility Testing

Infectious Diseases

Cholesterol Testing

Others By Distribution Channel Retail Pharmacies

Institutional Distribution

Online Pharmacies By Region North America

Latin America

Europe

Asia Pacific

Rest of the World Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share

• Tier 2 players

• Emerging players which are growing rapidly

• New Entrants FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis

• Key trends

• Key data-points affecting market growth Objectives of the Study:

• To provide with an exhaustive analysis on the global At Home Diagnostics Market by Application, by Distribution Channel, and by Region.

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

• Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement

The customization services offered are free of charge with purchase of any license of the report.

You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com